Christmas is supposed to be a time of warmth, indulgence, and merriment, surrounded by lights, high-quality food, and the ...

A paramilitary attack in April was one of the most brutal of Sudan’s civil war. Now, hunger is spreading as Western aid cuts have reduced U.N. rations.

The U.N. Human Rights Office says in a new report that more than 1,000 civilians were killed in a three-day attack by the ...

Real Madrid extended their lead against Alavés with executed second goal by Rodrygo. The goal came after fast break by Real Madrid with the ball quickly moved upfield through midfield to catch the ...

A drone attack by the Sudanese paramilitary forces hit a kindergarten in south-central Sudan, killing 50 people, including 33 children, a doctors’ group said. Paramedics on the scene in the town of ...

Dec. 6 (UPI) --Rapid Support Forces militia reportedly killed more than 100 civilians in the Sudanese city of Kalogi while also concealing tens of thousands of civilian deaths in El Fasher. RSF forces ...

Hit them with pace. It was England’s master plan for three years and it delivered in blood-curdling style, causing a jitteriness in Australian batsmen not seen for decades in an Ashes Test. The ...

With cold and flu season underway, one would hope others would be considerate enough to cough and sneeze into the crook of their elbow, slowing down the spread of contagious droplets into the air ...

NEW ORLEANS -- Patients experiencing major heart attacks had a lower risk of serious complications if they received a single injection of the investigational drug zalunfiban at first medical contact, ...

A rapid heart attack test could significantly accelerate diagnosis and treatment for patients, experts have revealed, promising to cut waiting times in emergency departments. To speed up diagnosis, ...

With new phase 3 data backing the ability of its emergency use zalunfiban to fend off further heart damage, CeleCor Therapeutics is one step closer to bringing a speedy new weapon to the race against ...

DEL MAR, Calif., Nov. 10, 2025 /PRNewswire/ -- Rapid treatment with CeleCor Therapeutics' investigational heart-attack drug, zalunfiban, resulted in higher levels of blood flow to the heart and an ...